Proteomics: A Promising Approach for Cancer Research Volume 2 Proteome signaling dysregulation in cancer, therapeutic interventions, and future perspectives provides an updated overview of scientific knowledge, achievements, and findings in the field of cancer proteomics. The field of cancer proteomics is very dynamic, with emerging trends specifically related to clinical solutions. The book content was developed to help readers get up to speed on the topic and easily apply learnings into research or clinical practice.
Volume 2 covers proteome signaling, their dysregulation to therapeutics options and future prospects in 17 different signaling pathways. It capitalizes the enormous interest in proteomics among academics and gives new viewpoints on this topic in cancer treatment. It is a valuable resource for cancer researchers, oncologists, graduate students, and members of biomedical field who are interested in the potential of proteomics in cancer research and treatment.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. List of contributors - p. xiii 7. Preface - p. xix 8. Chapter 1. Breast cancer: JAK/STAT signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 1 9. Chapter 2. Colorectal cancer: Notch signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 33 10. Chapter 3. Lung cancer: Akt/PKB signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 77 11. Chapter 4. Leukemia: Hedgehog signaling dysregulation, potential proteonomic techniques, therapeutic strategies, and future prospects - p. 105 12. Chapter 5. Gastric cancer: AMPK signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 145 13. Chapter 6. Pancreatic cancer: Wnt signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 173 14. Chapter 7. Cervical cancer: TGFβ signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 193 15. Chapter 8. Ovarian cancer: vascular endothelial growth factor signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 211 16. Chapter 9. Brain cancer: Hippo signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 227 17. Chapter 10. Endometrial cancer: cyclic adenosine monophosphate-dependent signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 253 18. Chapter 11. Lymphoma: TLR signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 297 19. Chapter 12. Thyroid cancer: MAPK/Erk signaling dysregulation potential proteomic techniques therapeutic strategies and future perspectives - p. 315 20. Chapter 13. Kidney cancer: mTOR signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 343 21. Chapter 14. Liver cancer: insulin signal transduction pathway dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 369 22. Chapter 15. Bladder cancer: PI3K/Akt/mTOR signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 409 23. Chapter 16. Skin cancer: Eph/ephrin signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 457 24. Chapter 17. Esophageal cancer: Nodal signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 471 25. Chapter 18. Hedgehog signaling pathway dysregulation in different cancers, potential molecular biomarkers, and therapeutic implications - p. 523 26. Chapter 19. Advancements in pancreatic cancer treatment: leveraging molecular targeted therapy, nanomedicine, photothermal therapy, and Wnt pathway modulation for enhanced patient outcomes - p. 551 27. Chapter 20. Bone cancer: focal adhesion kinase dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 581 28. Index - p. 603
Proteomics: A Promising Approach for Cancer Research Volume 2 Proteome signaling dysregulation in cancer, therapeutic interventions, and future perspectives provides an updated overview of scientific knowledge, achievements, and findings in the field of cancer proteomics. The field of cancer proteomics is very dynamic, with emerging trends specifically related to clinical solutions. The book content was developed to help readers get up to speed on the topic and easily apply learnings into research or clinical practice.
Volume 2 covers proteome signaling, their dysregulation to therapeutics options and future prospects in 17 different signaling pathways. It capitalizes the enormous interest in proteomics among academics and gives new viewpoints on this topic in cancer treatment. It is a valuable resource for cancer researchers, oncologists, graduate students, and members of biomedical field who are interested in the potential of proteomics in cancer research and treatment.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. List of contributors - p. xiii 7. Preface - p. xix 8. Chapter 1. Breast cancer: JAK/STAT signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 1 9. Chapter 2. Colorectal cancer: Notch signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 33 10. Chapter 3. Lung cancer: Akt/PKB signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 77 11. Chapter 4. Leukemia: Hedgehog signaling dysregulation, potential proteonomic techniques, therapeutic strategies, and future prospects - p. 105 12. Chapter 5. Gastric cancer: AMPK signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 145 13. Chapter 6. Pancreatic cancer: Wnt signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 173 14. Chapter 7. Cervical cancer: TGFβ signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 193 15. Chapter 8. Ovarian cancer: vascular endothelial growth factor signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 211 16. Chapter 9. Brain cancer: Hippo signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 227 17. Chapter 10. Endometrial cancer: cyclic adenosine monophosphate-dependent signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 253 18. Chapter 11. Lymphoma: TLR signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 297 19. Chapter 12. Thyroid cancer: MAPK/Erk signaling dysregulation potential proteomic techniques therapeutic strategies and future perspectives - p. 315 20. Chapter 13. Kidney cancer: mTOR signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 343 21. Chapter 14. Liver cancer: insulin signal transduction pathway dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 369 22. Chapter 15. Bladder cancer: PI3K/Akt/mTOR signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 409 23. Chapter 16. Skin cancer: Eph/ephrin signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 457 24. Chapter 17. Esophageal cancer: Nodal signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 471 25. Chapter 18. Hedgehog signaling pathway dysregulation in different cancers, potential molecular biomarkers, and therapeutic implications - p. 523 26. Chapter 19. Advancements in pancreatic cancer treatment: leveraging molecular targeted therapy, nanomedicine, photothermal therapy, and Wnt pathway modulation for enhanced patient outcomes - p. 551 27. Chapter 20. Bone cancer: focal adhesion kinase dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives - p. 581 28. Index - p. 603
